Riparian Pharmaceuticals, Inc.
Pharmaceutical company · Boston, Massachusetts, United States
Riparian Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Boston, Massachusetts, United States. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $3.7 million in total, most recently in 2022. It has reported private securities offerings to the US SEC, most recently $500,000 sold in a notice filed in 2018.
Riparian Pharmaceuticals at a glance
What does Riparian Pharmaceuticals do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $3.7 million in total (2013 to 2022). NIH funding came from the National Heart, Lung, and Blood Institute.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $500,000 sold (2018).
Frequently asked questions about Riparian Pharmaceuticals
Where is Riparian Pharmaceuticals headquartered?
Riparian Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts, United States.
What does Riparian Pharmaceuticals do?
Riparian Pharmaceuticals, Inc. is a pharmaceutical company.
Similar companies
- Transcode Therapeutics, Inc.Boston, Massachusetts, United States
- Akouos, Inc.Boston, Massachusetts, United States
- Astria Therapeutics, Inc.Boston, Massachusetts, United States
- Albireo Pharma, Inc.Boston, Massachusetts, United States
- Atea Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Rhythm Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Tango Therapeutics, Inc.Boston, Massachusetts, United States
- Paratek Pharmaceuticals, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences